Navigation Links
Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
Date:7/26/2012

DANBURY, Conn., July 26, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) announced today that the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH) has awarded Biodel a grant for the development of concentrated ultra-rapid-acting insulin formulations for use in an artificial pancreas, also known as a closed loop pump system.

"We are gratified to receive this award recognizing our innovations in the development of novel therapies to treat diabetes," said Dr. Errol De Souza, President and CEO of Biodel. "These funds will be focused on applying our proprietary technology for the development of ultra-rapid-acting insulin formulations for the treatment of insulin resistant patients and to assist in the development of effective artificial pancreas therapy."

The two-year grant, totaling $582,473, is intended to fund research to develop Biodel's proprietary ultra-rapid-acting insulin product candidate at high concentrations suited to provide sufficient quantities of insulin in an external artificial pancreas pump device that has a limited volume capacity. Currently, regular insulin at concentrations of 500 units per milliliter is used to treat extremely insulin resistant patients with diabetes. While these formulations are 5-times more concentrated than typical insulin presentations, they have a prolonged duration of action that may be undesirable for use with an artificial pancreas. Concentrated formulations of Biodel's ultra-rapid-acting insulin may be absorbed more rapidly than existing concentrated insulin formulations and may therefore become an important component of an effective step in the development of an artificial pancreas.

This research is supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award number R43DK096604. This press release an
'/>"/>

SOURCE Biodel Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
2. Biodel to Report Second Quarter Fiscal Year 2012 Financial Results on May 10, 2012
3. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
4. Biodel Announces $18.5 Million Private Placement
5. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
6. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
7. QBC Diagnostics Awarded GSA Contract
8. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
9. Northwest Bio Awarded $5.5 Million German Government Grant
10. Nonin Medical Awarded Novation Contract for Clinically Proven Pulse Oximeters
11. Elsevier / Gold Standards Kay Morgan Awarded NCPCP Highest Honor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , May 22, 2013 /PRNewswire-iReach/ -- World ... aligned with the latest trends and events, companies ... can predict where an industry is headed next, ... (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... with market research publisher GlobalData, offer decision makers ...
(Date:5/22/2013)... and MUNICH , May 22, 2013 /PRNewswire/ ... marketer of transcatheter aortic valve implantation (TAVI) systems for the ... results of the J enaValve Eval U ation of ... Pa T ients with S E vere Ao R tic ... . JUPITER is a post-market registry to evaluate five-year long ...
(Date:5/22/2013)... May 22, 2013  Milliman, Inc., a premier global ... its 2013 Milliman Medical Index (MMI), which measures the ... receiving healthcare benefits through an employer-sponsored preferred provider organization ... family in 2013 is $22,030. "For ... year on a percentage basis was the lowest in ...
Breaking Medicine Technology:Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 2First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 3First Results Of The JUPITER Registry On Long Term Performance And Safety Of The Transapical JenaValve TAVI System 4Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2
... Liberate Cosmetic Surgery hopes to raise awareness of ... confidence within the cosmetic surgery industry through the launch of ... their on-going activity on the subject, such as question and ... launching some exciting new initiatives online, that it hopes people ...
... 2011 The U.S. Food and Drug Administration ... (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Schizophrenia ... About 1 percent of Americans have this illness. ...
Cached Medicine Technology:Liberate Cosmetic Surgery aims to Highlight Cosmetic Surgery Industry Issues 2FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 2FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 3
(Date:5/22/2013)... ANN ARBORA University of Michigan study challenges previous ... League Baseball. , The study, a collaboration between ... and Florida, looks deeper into the controversial argument ... more strikes for pitchers of the same race. ... claim, said Jason Winfree, associate professor of sport ...
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Over the next ... United States is expected to more than double, topping ... research. The main factor driving the increase: an ... (AHA) and the American Stroke Association, was published May ... will absolutely strain the health care system," Dr. Bruce ...
(Date:5/22/2013)... may be reaping enormous income for patients whose ... contracted in their intensive care units. , In ... American Journal of Medical Quality , the ... an avoidable central line-associated bloodstream infection (CLABSI) costs ... a similar infection-free patient. Moreover, hospitals earn nearly ...
(Date:5/22/2013)... Phelps Memorial Hospital Center in Sleepy ... Center for individuals who would like to be screened ... is the deadliest form of cancer for both men and ... from lung cancer than from breast, colon and prostate cancer ... survival rates. It is well established that routine mammography ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Hurricane preparation ... your home. That’s why Amica Insurance is ... for the upcoming hurricane season. , “An important part ... Bryan Cook, a senior assistant vice president at Amica ... is before the threat of a storm.” , Flood ...
Breaking Medicine News(10 mins):Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2
... Peake: VA Reaches Out to Vets, Families in ... veterans and,their families during major emergencies, especially natural ... to deploy mobile pharmacies,that will provide vital medicine ... will also open up the facilities to help ...
... ACCU-CHEK(R) Aviva System is the first blood glucose monitoring system ... ... Foundation has,awarded its Ease-of-Use Commendation to the ACCU-CHEK(R) Aviva system,making ... Both the ACCU-CHEK Aviva meter and test strips and ...
... data from the SCIAMACHY instrument aboard ESA,s Envisat environmental ... elevated atmospheric carbon dioxide the most important greenhouse ... manmade emissions. , More than 30 billion tonnes of ... the atmosphere annually by human activities, mainly through the ...
... Remuda Programs for Eating Disorders,( http://www.remudaranch.com ), the ... and girls suffering from eating disorders,reports families often ... and,healing of eating disorders., "Part of our ... through a patient,s stay at Remuda," said Amy ...
... ... Industry, ... in convincing private insurers to adopt home,health monitoring technologies. Yet vendors ... education,regarding the benefits of home health monitoring technologies, according to,Private Insurance ...
... Systems,Corporation (NYSE: PER ) and ChinaSoft International ... develop mutually,beneficial opportunities in the Chinese Healthcare market., ... to take our broad,Healthcare IT expertise into the ... relationship with ChinaSoft in order to evaluate and,pursue ...
Cached Medicine News:Health News:VA Putting Mobile Pharmacies on the Road 2Health News:ACCU-CHEK(R) Aviva System Receives Arthritis Foundation's Ease-of-Use Commendation 2Health News:ACCU-CHEK(R) Aviva System Receives Arthritis Foundation's Ease-of-Use Commendation 3Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 2Health News:Envisat makes first ever observation of regionally elevated CO2 from manmade emissions 3Health News:Families Play a Role in the Development of Eating Disorders 2Health News:New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies 2Health News:New Healthcare Study Outlines Strategies to Increase Adoption of Home Health Monitoring Technologies 3Health News:Perot Systems and ChinaSoft to Pursue Chinese Healthcare Opportunities 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: